risperidone has been researched along with Thrombopenia in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhattacharjee, D | 1 |
Yerrapragada, D | 1 |
Chogtu, B | 1 |
Thomson, SR | 1 |
Assion, HJ | 1 |
Kolbinger, HM | 1 |
Rao, ML | 1 |
Laux, G | 1 |
2 other studies available for risperidone and Thrombopenia
Article | Year |
---|---|
Risperidone Induced Isolated Thrombocytopenia: A Rare Adverse Event.
Topics: Adult; Antipsychotic Agents; Humans; Male; Risperidone; Schizophrenia, Paranoid; Thrombocytopenia | 2018 |
Lymphocytopenia and thrombocytopenia during treatment with risperidone or clozapine.
Topics: Adult; Antipsychotic Agents; Clozapine; Humans; Lymphopenia; Male; Risperidone; Thrombocytopenia | 1996 |